SOPHiA GENETICS (SOPH) Exec. Chair Jurgi Camblong Sells Shares

What Happened
Jurgi Camblong, Executive Chairman and a director of SOPHiA GENETICS (SOPH), sold 8,500 shares on September 10, 2026. The reported weighted-average sale price was $7.66 per share, producing gross proceeds of approximately $65,120. This was a sale (not a purchase) and was made pursuant to a pre-established Rule 10b5-1(c) trading plan, which typically indicates the trades were pre-planned rather than a real-time signal of sentiment.

Key Details

• Transaction date: 2026-09-10 (Filed with the SEC on 2026-09-14). Filing date appears to fall within the usual two-business-day Form 4 window.
• Transaction type/code: S (Sale) — open market/private sale reported.
• Shares sold: 8,500; weighted-average price: $7.66; total proceeds ≈ $65,120.
• Price range: $7.57 to $7.79 (multiple executions). The filer offers to provide the number of shares sold at each price upon written request (footnote).
• Footnotes: F1 — executed under a duly adopted Rule 10b5-1(c) trading plan; F2 — weighted average price with multiple sale prices in the noted range.
• Shares owned after transaction: Not disclosed in the provided excerpt of the filing.

Context

• Sales under 10b5-1 plans are pre-arranged and common for insiders to meet diversification or liquidity needs; they are generally treated as routine rather than a direct market-confidence signal.
• No derivatives, option exercises, gifts or tax-withholding events are reported in this transaction.